North America Nicotine is the official importer of Nicotine and Nicotine Compounds from Contraf-Nicotex-Tobacco (CNT), a German based company. For more than 30 years, CNT along with its manufacturing partner Siegfried in Zofingen, Switzerland has been providing the highest quality nicotine to the top manufacturers all over the world.
Find Out More
We are part of the world's largest supplier of highly purified tobacco derived Nicotine to the pharmaceutical industry which they have done for the last 30 years. Our Nicotine is filed and referenced for pharmaceutical use in almost every country of the world. This is achieved through the numerous governmental inspections of manufacturing facility in Switzerland by the health authorities of these countries including the US FDA.
Our manufacturing process and analytical methods are fully validated resulting in a uniform quality of crystal clear Nicotine for every batch produced.
Find Out More
How Chemular can help your vaping business. Chemular is the leading provider of business improvement solutions and compliance systems for regulated industries.
The Natural Flavor Lines offer the convenience of a carrier, pre-diluted, to fit right into your current production process. These high strength blends will add just the right amount of flavor to your creations and can be formulated into any carrier you need. Choose Natural HC (Highly Concentrated), Natural MCT, Natural MCT+, or Natural OS. Want PG or VG? No problem, we can custom formulate. Want ultra pure? Check out our Pure Natural Premium line.
THE CNT GROUP
CONTRAF-NICOTEX-TOBACCO GmbH (CNT) is a family owned corporation under German law, with its headquarters in Heilbronn/ Germany. CNT is a worldwide operating company involved in growing, sourcing, developing, processing, extracting and the production of agriculturally originated products. The company operates in Argentina, Germany, India, Zambia, Zimbabwe, Brazil, USA and is represented with a sales office in Singapore.
Study from the MGH Tobacco Research & Treatment Center
The report, published in Nicotine and Tobacco Research online, provides the first longitudinal data about the effectiveness of e-cigarettes for cessation from a survey that reflects the U.S. population. The MGH team analyzed data from the first three years of the Population Assessment of Tobacco and Health (PATH) study, a survey representative of the U.S. adult population that interviews the same individuals each year.
Vapor Technology Association
VTA’s Board of Directors represents every facet of the vapor industry from large manufacturers of devices, leading manufacturers of e-liquids, major distribution companies and individual vape shops. Representing the new perspective and thought leadership in the vapor technology industry, VTA’s Board of Directors includes the following national and international industry veterans who have deep public policy, legal, compliance, industry and FDA regulatory experience:
Tobacco Harm Reduction 4 Life
Smoking cessation can manifest through many different avenues. What works better for one person, may not work as well for another. We recognize the importance of having options and support cessation through both conventional nicotine replacement therapies (NRT) andalternative tobacco harm reduction (THR) methods.Our mission is to help educate consumers by providing balanced and accurate information about tobacco harm reduction (THR).
What Do We Do?
Who Are We?